Colorectal cancerLocalized diseaseSystemic treatmentGuidelinesColorectal cancer (CRC) has a 5-year overall survival rate of over 60%. The decrease in the rate of metastatic disease is due to screening programs and the population's awareness of healthy lifestyle. Similarly, advancements in surgical ...
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ® )结肠癌续版本 1.2022 — 2022 年 2 月 25日NCCN.orgNCCN Guidelines for Patients ® 可于网址 www.nccn.org/patients获取版本 1.2022, 2022年 2⽉25 ⽇© 2022 National Comprehensive Cancer Network® (NCCN®), 保留所有权利...
(April 12, 2023) Colon Cancer Screening Methods: 2023 Update. Cureus 15(4): e37509. doi:10.7759/cureus.37509 ADVERTISEMENTArticle Authors etc. Metrics Media Comments Abstract Colorectal cancer (CRC) is a significant cause of morbidity and mortality worldwide. National screening guidelines have been...
The NCCN Colon/Rectal/Anal Cancers Guidelines panel believes that a multidisciplinary approach is necessary for managing colorectal cancer. The panel endorses the concept that treating patients in a clinical trial has priority over standard or accepted therapy. The recommended surgical procedure for resec...
Between 2013 and 2017, just 40% of patients with metastatic colon cancer received guideline-recommended biomarker testing that could have improved treatment decisions, according to findings from a retrospective study. Results also showed that adherence t
链接 jnccn.orgnih.govdoi.org 标识 DOI:10.6004/jnccn.2021.0012 摘要 This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have rece...
The majority of lung cancer cases can be traced to smoking tobacco. Additionally, genetics are believed to confer some susceptibility. Early detection offers the best hope for long-term survival. The choice of management options-including surgery, chemotherapy, and radiotherapy-depends on the ...
Colorectal cancer is generally more treatable when it is found early, before it has had a chance to spread. Find out the different methods of screening here.
Shorter RG. Risks of intestinal cancer in Crohn’s disease. Dis Colon Rectum 1983; 26 (10): 686–689. CASPubMedGoogle Scholar Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet 1990; 336 (8711): 357–359....
NEOADJUVANT THERAPY FOR RECTAL CANCER: DOES THE INTERVAL BETWEEN CHEMORADIATION AND SURGERY MATTER? L. LobatoD. GeislerA. da Luz MoreiraV. FazioAnnual Meeting of the American-Society-of-Colon-and-Rectal-Surgeons L Lobato,D Geisler,ADL Moreira,... - Meeting of the American-society-of-colon-and...